OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neurobiological basis of narcolepsy
Carrie E. Mahoney, Andrew C. Cogswell, Igor J. Koralnik, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 2, pp. 83-93
Open Access | Times Cited: 216

Showing 26-50 of 216 citing articles:

A review of physiological functions of orexin: From instinctive responses to subjective cognition
LiBo Xia, Haiyan Liu, Bi Yan Wang, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e34206-e34206
Open Access | Times Cited: 14

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13

Narcolepsy and rapid eye movement sleep
Francesco Biscarini, Lucie Barateau, Fabio Pizza, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 4

Pathophysiologie der Narkolepsie
Ulf Kallweit, Thomas Dittmar
Somnologie - Schlafforschung und Schlafmedizin (2025)
Closed Access

The Metabolic Basis of Cancer-Related Fatigue
Robert Dantzer, Brandon Chelette, Elisabeth G. Vichaya, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106035-106035
Closed Access

Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access

Narcolepsy as a potential risk factor for Schizophrenia
Reyhane Eghtedarian, Anniina Tervi, Samuel E. Jones, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access

The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19
Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 545-545
Open Access

Alzheimer’s disease with depression: clinical characteristics and potential mechanisms involving orexin and brain atrophy
Jing Li, Teng-hong Lian, Jinghui Li, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access

Determinants of substance use patterns in patients with narcolepsy type 1: a multi-center comparative cross-sectional study
Laure Peter‐Derex, Emmanuel Fort, Benjamin Putois, et al.
Sleep Medicine (2025) Vol. 129, pp. 148-166
Open Access

To sleep or not to sleep – Effects on memory in normal aging and disease
Daniel Kroeger, Ramalingam Vetrivelan
Aging Brain (2023) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 12

Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia
Emmanuel Mignot, Richard Bogan, Hélène A. Emsellem, et al.
SLEEP (2023) Vol. 46, Iss. 9
Open Access | Times Cited: 11

Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
Jari K. Gool, Zhongxing Zhang, Rolf Fronczek, et al.
Sleep Medicine (2024) Vol. 116, pp. 105-114
Open Access | Times Cited: 4

Bidirectional gut-brain communication: A role for orexin-A
Cristina Mediavilla
Neurochemistry International (2020) Vol. 141, pp. 104882-104882
Closed Access | Times Cited: 30

Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui� Zhang, David A. Perrey, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8806-8825
Open Access | Times Cited: 23

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
Yves Dauvilliers, Thomas Roth, Richard Bogan, et al.
SLEEP (2023) Vol. 46, Iss. 11
Open Access | Times Cited: 9

Vagus nerve stimulation for the treatment of narcolepsy
Yaroslav Winter, Katharina Sandner, Claudio L. Bassetti, et al.
Brain stimulation (2024) Vol. 17, Iss. 1, pp. 83-88
Open Access | Times Cited: 3

Tetrad of Narcolepsy Type 1: Treatment and Management
Kanishka Gandhi, Suraiya Ferdous
Cureus (2024)
Open Access | Times Cited: 3

A vertebrate family without a functional Hypocretin/Orexin arousal system
Vassilis Bitsikas, Fabien Cubizolles, Alexander F. Schier
Current Biology (2024) Vol. 34, Iss. 7, pp. 1532-1540.e4
Closed Access | Times Cited: 3

Sleep Disorders
Rebecca Robbins, Stuart F. Quan
NEJM Evidence (2024) Vol. 3, Iss. 10
Closed Access | Times Cited: 3

The neuroanatomy and neurochemistry of sleep-wake control
Heinrich S. Gompf, Christelle Anaclet
Current Opinion in Physiology (2019) Vol. 15, pp. 143-151
Open Access | Times Cited: 27

Scroll to top